- 世联博研公司现货供应OZ BIOSCIENCES SAS品牌订货号为CF10050的...
- 世联博研公司现货供应OZ BIOSCIENCES SAS品牌订货号为CF10050的...
- 2020年15月FDA批准的新药_新浪医药新闻
- 汽车之家_看车买车用车 都回汽车之家
- OZ Biosciences代理报价
- 谁能帮我验下真假 谢谢大佬们
- 求加精:Avanti Polar Lipids标准品 进口Avanti Polar品牌清关代理,是...
- OZ Biosciences代理2013年OZ Biosciences产品中国代理...
- BD Biosciences产品目录 65折促销
- oz biosciences公司|产品资讯
- ecmbio公司,ecmbio官网,ecmbio代理商,ecmbio销售,免疫 ...
- OZ biosciences® 專區 科研市集
3D-Fect™ is suitable for all kinds of scaffolds and cells. This 3D Transfection Reagent is specifically developed to directly transfect cells cultured in 3D scaffolds. This reagent is based on a novel technology that adds a third dimension to cell culture and transfection. 3D matrices not only add a third dimension to cells’ environment, they also allow creating significant differences in cellular characteristics and behaviours.
Because 3D matrices are routinely used in basic research and therapeutic applications, OZ Biosciences has developed 3D-Fect™ Transfection Reagent specific for 3D-scaffolds. In this way, scaffold-based 3D matrices activated with 3D-Fect™/DNA complexes are colonized by cells which are subsequently transfected in situ and in a more natural environment. This method allows studying tissue engineering and regeneration, tumour invasion, neural differentiation, cellular polarization, tissue formation,colonization, neurite growth...
For Gene Silencing applications, please refer to si3D-Fect
- Highly efficient: cell lines and primary cells
- Specific for 3D Scaffolds
- Compatible with all types of nucleic acids
- Completely biodegradable
- Long term protein expression
- Serum Compatible
Sizes:
- 250 µL: Good for 65 to 125 transfections with 1 µg of DNA
- 500 µL: Good for 125 to 250 transfections with 1 µg of DNA
- 1000 µL: Good for 250 to 500 transfections with 1 µg of DNA
Storage: +4°C
Shipping Conditions: Room temperature
Please log in or register to see the prices for your country
自2003年以来,OZ Biosciences为全球科学界和制药行业创建,开发和生产专门用于转染和转导工具的创新分子递送系统。OZ Biosciences专注于体外和体内应用的生物分子(例如DNA,RNA和蛋白质)的输送技术。在过去的几年中,生命科学经历了技术革命。在基因组学,功能基因组学和蛋白质组学领域所取得的进展为更好地理解基本生物学过程和开发下一代药物创造了绝佳的机会。

